Infusion of docosahexaenoic acid protects against myocardial infarction

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 90, Issue 4, 2014, Pages 139-143

  Richard, D ^a   Oszust, F ^b   Guillaume, C ^c   Millart, H ^b   Laurent Maquin, D ^c   Brou, C ^d   Bausero, P ^a   Visioli, F ^e  

^a SORBONNE UNIVERSITÉ   (France)

^b Reims University Hospital   (France)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^d INSTITUT PASTEUR   (France)

^e IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Cardioprotection; Docosahexaenoic acid; Ischemia; Notch; Reperfusion

Indexed keywords

BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; PROTEIN HEY1; UNCLASSIFIED DRUG; ANTIOXIDANT; CARDIOTONIC AGENT; NOTCH RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART INJURY; HEART MUSCLE; HEART MUSCLE CONTRACTILE FORCE; HEART PROTECTION; MALE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; HEART VENTRICLE FUNCTION; IN VITRO STUDY; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; CARDIOTONIC AGENTS; DOCOSAHEXAENOIC ACIDS; IN VITRO TECHNIQUES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION;

EID: 84896389853     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.01.001     Document Type: Article

References (24)

1. Grey A., Bolland M. Clinical trial evidence and use of fish oil supplements. JAMA Intern. Med. 2013, 1-4.
2. Billman G.E., Kang J.X., Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 1999, 99:2452-2457.
3. Schrepf R., Limmert T., Claus Weber P., Theisen K., Sellmayer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004, 363:1441-1442.
4. Heidt M.C., Vician M., Stracke S.K., Stadlbauer T., Grebe M.T., Boening A., Vogt P.R., Erdogan A. Beneficial effects of intravenously administered n-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac. Cardiovasc. Surg. 2009, 57:276-280.
5. Xiao Y.F., Sigg D.C., Ujhelyi M.R., Wilhelm J.J., Richardson E.S., Iaizzo P.A. Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2212-H2218.
6. Kromhout D., de Goede J. Update on cardiometabolic health effects of omega-3 fatty acids. Curr. Opin. Lipidol. 2013.
7. Belayev L., Khoutorova L., Atkins K.D., Eady T.N., Hong S., Lu Y., Obenaus A., Bazan N.G. Docosahexaenoic acid therapy of experimental ischemic stroke. Transl. Stroke Res. 2011, 2:33-41.
8. Eady T.N., Khoutorova L., Anzola D.V., Hong S.H., Obenaus A., Mohd-Yusof A., Bazan N.G., Belayev L. Acute treatment with docosahexaenoic Acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats. PLoS ONE 2013, 8:e77237.
9. Dikic I., Schmidt M.H. Notch: implications of endogenous inhibitors for therapy. Bioessays 2010, 32:481-487.
10. Phng L.K., Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev. Cell 2009, 16:196-208.
11. Caillier B., Pilote S., Patoine D., Levac X., Couture C., Daleau P., Simard C., Drolet B. Metabolic syndrome potentiates the cardiac action potential-prolonging action of drugs: a possible 'anti-proarrhythmic' role for amlodipine. Pharmacol. Res. 2012, 65:320-327.
12. Sagach V.F., Scrosati M., Fielding J., Rossoni G., Galli C., Visioli F. The water-soluble vitamin E analogue Trolox protects against ischaemia/reperfusion damage in vitro and ex vivo. A comparison with vitamin E. Pharmacol. Res. 2002, 45:435-439.
13. Pasini E., Solfrini R., Bachetti T., Marino M., Bernocchi P., Visioli F., Ferrari R. The blood perfused isolated heart: characterization of the model. Basic Res. Cardiol. 1999, 94:215-222.
14. Fukuzawa K., Fujisaki A., Akai K., Tokumura A., Terao J., Gebicki J.M. Measurement of phosphatidylcholine hydroperoxides in solution and in intact membranes by the ferric-xylenol orange assay. Anal. Biochem. 2006, 359:18-25.
15. Ceconi C., Cargnoni A., Francolini G., Parinello G., Ferrari R. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart. Cardiovasc. Res. 2009, 84:72-82.
16. Aarsetoey H., Aarsetoey R., Lindner T., Staines H., Harris W.S., Nilsen D.W. Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. Lipids 2011, 46:151-161.
17. Rise P., Eligini S., Ghezzi S., Colli S., Galli C. Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76:363-369.
18. Delbosc S., Glorian M., Le Port A.S., Bereziat G., Andreani M., Limon I. The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9. Am. J. Pathol 2008, 172:1430-1440.
19. Giordano E., Visioli F. Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions. Prostaglandins Leukot. Essent. Fatty Acids 2014, 90:1-4.
20. Harper C.R., Edwards M.J., DeFilippis A.P., Jacobson T.A. Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J. Nutr. 2006, 136:83-87.
21. Harris W.S., Dayspring T.D., Moran T.J. Omega-3 fatty acids and cardiovascular disease: new developments and applications. Postgrad. Med. 2013, 125:100-113.
22. Vedtofte M.S., Jakobsen M.U., Lauritzen L., Heitmann B.L. Dietary alpha-linolenic acid, linoleic acid, and n-3 long-chain PUFA and risk of ischemic heart disease. Am. J. Clin. Nutr. 2011, 94:1097-1103.
23. Richard D., Wolf C., Barbe U., Kefi K., Bausero P., Visioli F. Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signaling pathway. Biochem. Biophys. Res. Commun. 2009, 389:516-522.
24. Richard et al., in preparation.